DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Giorgio, Annabella Di ^a   Smith, Ryan M ^b   Fazio, Leonardo ^c   D'Ambrosio, Enrico ^c   Gelao, Barbara ^c   Tomasicchio, Aldo ^c   Selvaggi, Pierluigi ^c   Taurisano, Paolo ^c   Quarto, Tiziana ^c,d   Masellis, Rita ^c   Rampino, Antonio ^c   Caforio, Grazia ^c   Popolizio, Teresa ^a   Blasi, Giuseppe ^c   Sadee, Wolfgang ^b   Bertolino, Alessandro ^a,c,e  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF HELSINKI   (Finland)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; CHRNA5 PROTEIN, HUMAN; DRD2 PROTEIN, HUMAN; NERVE PROTEIN; NICOTINIC RECEPTOR;

ADULT; ARTICLE; BRAIN SIZE; CHRNA5 GENE; CONTROLLED STUDY; DRD2 GENE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENE INTERACTION; GENETIC VARIABILITY; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MENTAL TASK; MORPHOMETRICS; NEUROMODULATION; NORMAL HUMAN; PHENOTYPIC VARIATION; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; TASK PERFORMANCE; WORKING MEMORY; GENETICS; GENOTYPE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; SHORT TERM MEMORY; YOUNG ADULT;

ADULT; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D2; RECEPTORS, NICOTINIC; YOUNG ADULT;

EID: 84901249245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095997     Document Type: Article

References (92)

1. Ando J, Ono Y, Wright MJ (2001) Genetic structure of spatial and verbal working memory. Behav Genet 31: 615-624. (Pubitemid 34112056)
2. Luciano M, Wright M, Smith GA, Geffen GM, Geffen LB, et al. (2001) Genetic covariance among measures of information processing speed, working memory, and IQ. Behav Genet 31: 581-592. (Pubitemid 34112053)
3. Polderman TJ, Gosso MF, Posthuma D, Van Beijsterveldt TC, Heutink P, et al. (2006) A longitudinal twin study on IQ, executive functioning, and attention problems during childhood and early adolescence. Acta Neurol Belg 106: 191-207. (Pubitemid 46243057)
4. Goldman-Rakic PS (1995) Architecture of the prefrontal cortex and the central executive. Ann N Y Acad Sci 769: 71-83.
5. Wang Y, Markram H, Goodman PH, Berger TK, Ma J, et al. (2006) Heterogeneity in the pyramidal network of the medial prefrontal cortex. Nat Neurosci 9: 534-542.
6. Blokland GA, McMahon KL, Thompson PM, Martin NG, de Zubicaray GI, et al. (2011) Heritability of working memory brain activation. J Neurosci 31: 10882-10890.
7. Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, et al. (2003) Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160: 709-719. (Pubitemid 41079604)
8. Robbins TW, Roberts AC (2007) Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 17 Suppl 1: i151-160.
9. Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, et al. (2011) DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Proc Natl Acad Sci U S A 108: 1158-1163.
10. Papaleo F, Burdick MC, Callicott JH, Weinberger DR (2013) Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans. Mol Psychiatry.
11. Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, et al. (2007) Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci U S A 104: 12536-12541. (Pubitemid 47206173)
12. Tritsch NX, Sabatini BL (2012) Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76: 33-50.
13. Wang M, Vijayraghavan S, Goldman-Rakic PS (2004) Selective D2 receptor actions on the functional circuitry of working memory. Science 303: 853-856. (Pubitemid 38174667)
14. Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1-58.
15. Zhou X, Qi XL, Douglas K, Palaninathan K, Kang HS, et al. (2011) Cholinergic modulation of working memory activity in primate prefrontal cortex. J Neurophysiol 106: 2180-2188.
16. Croxson PL, Kyriazis DA, Baxter MG (2011) Cholinergic modulation of a specific memory function of prefrontal cortex. Nat Neurosci 14: 1510-1512.
17. Chudasama Y, Dalley JW, Nathwani F, Bouger P, Robbins TW (2004) Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn Mem 11: 78-86. (Pubitemid 38167061)
18. Granon S, Poucet B, Thinus-Blanc C, Changeux JP, Vidal C (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology (Berl) 119: 139-144.
19. Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184: 523-539. (Pubitemid 43255869)
20. Chan WK, Wong PT, Sheu FS (2007) Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory. Neuropharmacology 52: 1641-1649. (Pubitemid 46843139)
21. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138: 217-230. (Pubitemid 28365487)
22. Levin ED, Rose JE, Abood L (1995) Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 51: 369-373.
23. Woodruff-Pak DS (2003) Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning. Behav Brain Res 143: 159-167.
24. Spinelli S, Ballard T, Feldon J, Higgins GA, Pryce CR (2006) Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys. Neuropharmacology 51: 238-250. (Pubitemid 44061881)
25. Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, et al. (2010) Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry 67: 715-721.
26. Howe MN, Price IR (2001) Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia. Int Psychogeriatr 13: 465-475. (Pubitemid 34326975)
27. Gotti C, Zoli M, Clementi F (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27: 482-491. (Pubitemid 44251225)
28. Sihver W, Gillberg PG, Nordberg A (1998) Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography. Neuroscience 85: 1121-1133. (Pubitemid 28293418)
29. Poorthuis RB, Bloem B, Schak B, Wester J, de Kock CP, et al. (2013) Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cereb Cortex 23: 148-161.
30. Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, et al. (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78: 703-711.
31. Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, et al. (1996) Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature 380: 347-351.
32. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, et al. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12: 2765-2784.
33. Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, et al. (2003) The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 63: 1059-1066. (Pubitemid 36529924)
34. Wada E, McKinnon D, Heinemann S, Patrick J, Swanson LW (1990) The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res 526: 45-53. (Pubitemid 20273561)
35. Winzer-Serhan UH, Leslie FM (2005) Expression of alpha5 nicotinic acetylcholine receptor subunit mRNA during hippocampal and cortical development. J Comp Neurol 481: 19-30. (Pubitemid 39578767)
36. Bailey CD, De Biasi M, Fletcher PJ, Lambe EK (2010) The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci 30: 9241-9252.
37. Bailey CD, Alves NC, Nashmi R, De Biasi M, Lambe EK (2012) Nicotinic alpha5 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons. Biol Psychiatry 71: 120-128.
38. Levin ED, Rose JE (1991) Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 27: 125-128.
39. Levin ED, Castonguay M, Ellison GD (1987) Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol 48: 206-212. (Pubitemid 18078550)
40. Levin ED, McGurk SR, South D, Butcher LL (1989) Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav Neural Biol 51: 270-277. (Pubitemid 19068797)
41. McGurk SR, Levin ED, Butcher LL (1989) Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. Psychopharmacology (Berl) 99: 371-373. (Pubitemid 19244117)
42. Levin ED, McGurk SR, Rose JE, Butcher LL (1989) Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555. Pharmacol Biochem Behav 33: 919-922. (Pubitemid 19284312)
43. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, et al. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
44. Centonze D, Gubellini P, Usiello A, Rossi S, Tscherter A, et al. (2004) Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience 129: 157-166. (Pubitemid 39360951)
45. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, et al. (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during workingmemory. Proc Natl Acad Sci U S A 104: 20552-20557.
46. Bertolino A, Fazio L, Caforio G, Blasi G, Rampino A, et al. (2009) Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 132: 417-425.
47. Bertolino A, Taurisano P, Pisciotta NM, Blasi G, Fazio L, et al. (2010) Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One 5: e9348.
48. Sasabe T, Furukawa A, Matsusita S, Higuchi S, Ishiura S (2007) Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients. Neurosci Lett 412: 139-142. (Pubitemid 46074350)
49. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, et al. (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762.
50. Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, et al. (2014) The Dopamine Receptor D2 (DRD2) SNP rs1076560 is Associated with Opioid Addiction. Ann Hum Genet 78: 33-39.
51. Voisey J, Swagell CD, Hughes IP, van Daal A, Noble EP, et al. (2012) A DRD2 and ANKK1 haplotype is associated with nicotine dependence. Psychiatry Res 196: 285-289.
52. Wei J, Chu C, Wang Y, Yang Y, Wang Q, et al. (2012) Association study of 45 candidate genes in nicotine dependence in Han Chinese. Addict Behav 37: 622-626.
53. Connor JP, Young RM, Lawford BR, Saunders JB, Ritchie TL, et al. (2007) Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphism. Addict Behav 32: 310-319. (Pubitemid 44932206)
54. Wang TY, Lee SY, Chen SL, Huang SY, Chang YH, et al. (2013) Association between DRD2, 5-HTTLPR, and ALDH2 genes and specific personality traits in alcohol- and opiate-dependent patients. Behav Brain Res 250: 285-292.
55. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, et al. (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 1163-1171.
56. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49. (Pubitemid 46152543)
57. Smith RM, Alachkar H, Papp AC, Wang D, Mash DC, et al. (2011) Nicotinic alpha5 receptor subunit mRNA expression is associated with distant 5 9 upstream polymorphisms. Eur J Hum Genet 19: 76-83.
58. Wang JC, Spiegel N, Bertelsen S, Le N, McKenna N, et al. (2013) Cis-Regulatory Variants Affect CHRNA5 mRNA Expression in Populations of African and European Ancestry. PLoS One 8: e80204.
59. Kuryatov A, Berrettini W, Lindstrom J (2011) Acetylcholine receptor (AChR) alpha5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (alpha4beta2)(2)alpha5 AChR function. Mol Pharmacol 79: 119-125.
60. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, et al. (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16: 24-35. (Pubitemid 46152542)
61. Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, et al. (2009) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet 150B: 453-466.
62. Winterer G, Mittelstrass K, Giegling I, Lamina C, Fehr C, et al. (2010) Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet 153B: 1448-1458.
63. Hong LE, Yang X, Wonodi I, Hodgkinson CA, Goldman D, et al. (2011) A CHRNA5 allele related to nicotine addiction and schizophrenia. Genes Brain Behav 10: 530-535.
64. Jackson KJ, Fanous AH, Chen J, Kendler KS, Chen X (2013) Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder. Psychiatr Genet 23: 20-28.
65. Falcone M, Smith RM, Chenoweth MJ, Kumar Bhattacharjee A, Kelsoe JR, et al. (2013) Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology 38: 2327-2337.
66. Lambe EK, Krimer LS, Goldman-Rakic PS (2000) Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20: 8780-8787.
67. First M, Gibbon M, Spitzer R, Williams J (1996) Guide for the structured clinical interview for DSM-IV axis I disorders-Research version. New York: Biometrics Research.
68. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
69. Hong LE, Hodgkinson CA, Yang Y, Sampath H, Ross TJ, et al. (2010) A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci U S A 107: 13509-13514.
70. Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, et al. (2008) Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 118: 2200-2208. (Pubitemid 351872338)
71. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38: 95-113.
72. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26: 839-851. (Pubitemid 40825026)
73. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. Neuroimage 11: 805-821.
74. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE (2004) Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22: 676-687. (Pubitemid 38759430)
75. Markett SA, Montag C, Reuter M (2010) The association between dopamine DRD2 polymorphisms and working memory capacity is modulated by a functional polymorphism on the nicotinic receptor gene CHRNA4. J Cogn Neurosci 22: 1944-1954.
76. Sullivan D, Pinsonneault JK, Papp AC, Zhu H, Lemeshow S, et al. (2013) Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Transl Psychiatry 3: e222.
77. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98: 6917-6922. (Pubitemid 32538317)
78. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100: 6186-6191. (Pubitemid 36576952)
79. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, et al. (2002) Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51: 156-164. (Pubitemid 34111437)
80. Calabresi P, Picconi B, Parnetti L, Di Filippo M (2006) A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 5: 974-983. (Pubitemid 44556553)
81. Kuehn BM (2006) Link between smoking and mental illness may lead to treatments. JAMA 295: 483-484.
82. Pickel VM, Chan J, Nirenberg MJ (2002) Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 45: 113-124. (Pubitemid 34742947)
83. Kassam SM, Herman PM, Goodfellow NM, Alves NC, Lambe EK (2008) Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors. J Neurosci 28: 8756-8764.
84. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, et al. (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22: 8785-8789. (Pubitemid 35379047)
85. Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ (2012) Striatal alpha5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci 32: 2352-2356.
86. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, et al. (2012) Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75: 58-64.
87. Mechawar N, Descarries L (2001) The cholinergic innervation develops early and rapidly in the rat cerebral cortex: a quantitative immunocytochemical study. Neuroscience 108: 555-567. (Pubitemid 33660715)
88. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH (1997) New evidence for neurotransmitter influences on brain development. Trends Neurosci 20: 269-274. (Pubitemid 27261459)
89. Sherren N, Pappas BA (2005) Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood. Neuroscience 136: 445-456. (Pubitemid 41607893)
90. Kristt DA (1979) Acetylcholinesterase-containing neurons of layer VIb in immature neocortex: possible component of an early formed intrinsic cortical circuit. Anat Embryol (Berl) 157: 217-226.
91. Lipton SA, Frosch MP, Phillips MD, Tauck DL, Aizenman E (1988) Nicotinic antagonists enhance process outgrowth by rat retinal ganglion cells in culture. Science 239: 1293-1296.
92. Pugh PC, Berg DK (1994) Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J Neurosci 14: 889-896. (Pubitemid 24043939)